Cash flow Ecolab Inc.

Equities

ECL

US2788651006

Specialty Chemicals

Market Closed - Nyse Other stock markets 21:00:03 12/05/2026 BST			5-day change	1st Jan Change
251.70 ^USD	+0.24%		-1.52%	-4.12%

05-12	DA Davidson Cuts Price Target on Ecolab to $287 From $300, Keeps Buy/Add Rating	MT
05-06	Ecolab Inc. announces Quarterly dividend, payable on July 15, 2026	CI

962793727cd4179865b321d.tpHTvn8iium4gpHvfqsCs_z2Vi-oCuj-Qz4gJZgx7xs.hdaq1Ths3ofR0Pu2MfEz_5vDOEDnQIK0IlVSbsJdh3zGx-rzFUjlgvPl8g

Published financial data: ECOLAB INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	12.73B	14.19B	15.32B	15.74B	16.08B
Total Revenues	12.73B	14.19B	15.32B	15.74B	16.08B
Cost of Goods Sold, Total	7.52B	8.76B	9.13B	8.89B	8.92B
Gross Profit	5.21B	5.43B	6.19B	6.85B	7.16B
Selling General & Admin Expenses, Total	3.34B	3.58B	4B	4.18B	4.21B
Other Operating Expenses, Total	3.34B	3.58B	4B	4.18B	4.21B
Operating Income	1.87B	1.85B	2.18B	2.67B	2.95B
Interest Expense, Total	-198M	-252M	-349M	-340M	-306M
Interest And Investment Income	12.3M	8.5M	52.2M	57.8M	65.1M
Net Interest Expenses	-185M	-244M	-297M	-282M	-241M
Other Non Operating Income (Expenses)	-1.6M	-1M	2.7M	-	-
EBT, Excl. Unusual Items	1.68B	1.6B	1.89B	2.39B	2.71B
Restructuring Charges	-36.6M	-107M	-85.7M	-125M	-136M
Merger & Related Restructuring Charges	-34.9M	-39.5M	-16.1M	-12.6M	-36.1M
Asset Writedown	-	-	-	-	-
Other Unusual Items	-195M	-114M	-32.1M	322M	9.4M
EBT, Incl. Unusual Items	1.41B	1.34B	1.76B	2.57B	2.55B
Income Tax Expense	270M	234M	362M	439M	455M
Earnings From Continuing Operations	1.14B	1.11B	1.39B	2.13B	2.09B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	1.14B	1.11B	1.39B	2.13B	2.09B
Minority Interest	-14.1M	-17.2M	-20.7M	-19.5M	-17.7M
Net Income - (IS)	1.13B	1.09B	1.37B	2.11B	2.08B
Net Income to Common Incl Extra Items	1.13B	1.09B	1.37B	2.11B	2.08B
Net Income to Common Excl. Extra Items	1.13B	1.09B	1.37B	2.11B	2.08B
Per Share Items
Net EPS - Basic	3.95	3.83	4.82	7.43	7.33
Basic EPS - Continuing Operations	3.95	3.83	4.82	7.43	7.33
Basic Weighted Average Shares Outstanding	286M	285M	285M	284M	283M
Net EPS - Diluted	3.91	3.81	4.79	7.37	7.28
Diluted EPS - Continuing Operations	3.91	3.81	4.79	7.37	7.28
Diluted Weighted Average Shares Outstanding	289M	287M	286M	287M	285M
Normalized Basic EPS	3.62	3.46	4.07	5.18	5.92
Normalized Diluted EPS	3.59	3.44	4.05	5.14	5.88
Dividend Per Share	1.95	2.06	2.16	2.36	2.68
Payout Ratio	50.13	55.22	44.98	31.45	36.31
Supplemental Items
EBITDA	2.71B	2.79B	3.11B	3.61B	3.93B
EBITA	2.11B	2.17B	2.49B	2.97B	3.26B
EBIT	1.87B	1.85B	2.18B	2.67B	2.95B
EBITDAR	2.89B	2.98B	3.32B	3.82B	4.16B
Total Revenues (As Reported)	12.73B	14.19B	15.32B	15.74B	16.08B
Effective Tax Rate - (Ratio)	19.11	17.46	20.65	17.09	17.84
Current Domestic Taxes	30.9M	146M	138M	301M	265M
Current Foreign Taxes	240M	231M	280M	323M	226M
Total Current Taxes	271M	377M	418M	624M	491M
Deferred Domestic Taxes	3.6M	-78.9M	-40.1M	-143M	-5.5M
Deferred Foreign Taxes	-4.5M	-63.7M	-15M	-41.5M	-30.7M
Total Deferred Taxes	-900K	-143M	-55.1M	-185M	-36.2M
Normalized Net Income	1.04B	986M	1.16B	1.47B	1.68B
Non-Cash Pension Expense	-37.1M	-26.9M	-62.2M	-53.1M	-52.8M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	186M	190M	192M	207M	202M
Net Rental Expense, Total	179M	197M	215M	218M	230M
Imputed Operating Lease Interest Expense	34.85M	43.68M	67.7M	69.75M	65.21M
Imputed Operating Lease Depreciation	145M	153M	148M	148M	165M
Stock-Based Comp., Other (Total)	89.5M	87.8M	95.1M	135M	137M
Total Stock-Based Compensation	89.5M	87.8M	95.1M	135M	137M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	360M	599M	920M	1.26B	646M
Total Cash And Short Term Investments	360M	599M	920M	1.26B	646M
Accounts Receivable, Total	2.48B	2.7B	2.83B	2.86B	3.37B
Other Receivables	151M	184M	187M	163M	230M
Total Receivables	2.63B	2.88B	3.02B	3.03B	3.6B
Inventory	1.49B	1.79B	1.5B	1.46B	1.49B
Prepaid Expenses	121M	124M	144M	151M	160M
Other Current Assets, Total	84.5M	96.7M	62.4M	124M	62.9M
Total Current Assets	4.69B	5.49B	5.64B	6.03B	5.96B
Gross Property Plant And Equipment	7.58B	7.7B	8.21B	8.91B	9.88B
Accumulated Depreciation	-3.89B	-3.96B	-4.18B	-4.44B	-4.84B
Net Property Plant And Equipment	3.69B	3.74B	4.03B	4.48B	5.04B
Goodwill	8.06B	8.01B	8.15B	7.91B	9.23B
Other Intangibles, Total	4.22B	3.68B	3.49B	3.31B	3.69B
Deferred Tax Assets Long-Term	121M	108M	119M	156M	181M
Other Long-Term Assets, Total	425M	427M	413M	515M	602M
Total Assets	21.21B	21.46B	21.85B	22.39B	24.7B
Liabilities
Accounts Payable, Total	1.38B	1.73B	1.57B	1.81B	2.07B
Accrued Expenses, Total	1.05B	1.07B	1.32B	1.41B	1.49B
Short-term Borrowings	408M	3.7M	1.8M	3.6M	111M
Current Portion of Long-Term Debt	2.5M	501M	629M	612M	759M
Current Portion of Leases	115M	108M	126M	142M	165M
Current Income Taxes Payable	104M	198M	159M	127M	134M
Unearned Revenue Current, Total	91.7M	116M	111M	102M	173M
Other Current Liabilities	394M	482M	437M	582M	627M
Total Current Liabilities	3.55B	4.21B	4.35B	4.79B	5.53B
Long-Term Debt	8.34B	8.06B	7.54B	6.93B	7.23B
Long-Term Leases	291M	351M	439M	598M	728M
Pension & Other Post Retirement Benefits	894M	670M	652M	635M	546M
Deferred Tax Liability Non Current	622M	506M	418M	280M	330M
Other Non Current Liabilities	254M	406M	382M	366M	519M
Total Liabilities	13.95B	14.21B	13.77B	13.6B	14.89B
Common Stock, Total	364M	365M	366M	368M	369M
Additional Paid In Capital	6.46B	6.58B	6.77B	7.16B	7.52B
Retained Earnings	8.81B	9.32B	10.08B	11.52B	12.83B
Treasury Stock	-6.78B	-7.3B	-7.31B	-8.31B	-9.08B
Comprehensive Income and Other	-1.63B	-1.73B	-1.85B	-1.98B	-1.87B
Total Common Equity	7.22B	7.24B	8.04B	8.76B	9.77B
Minority Interest	28.9M	22.5M	27.5M	31.9M	33.7M
Total Equity	7.25B	7.26B	8.07B	8.79B	9.8B
Total Liabilities And Equity	21.21B	21.46B	21.85B	22.39B	24.7B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	287M	284M	286M	283M	282M
ECS Total Common Shares Outstanding	287M	284M	285M	283M	282M
Book Value / Share	25.18	25.43	28.18	30.91	34.65
Tangible Book Value	-5.06B	-4.46B	-3.6B	-2.46B	-3.14B
Tangible Book Value Per Share	-17.65	-15.67	-12.6	-8.68	-11.15
Total Debt	9.16B	9.03B	8.73B	8.28B	9B
Net Debt	8.8B	8.43B	7.81B	7.03B	8.35B
Debt Equivalent of Unfunded Proj. Benefit Obligation	646M	447M	443M	407M	305M
Debt Equivalent Oper. Leases	1.44B	1.58B	1.72B	1.74B	1.84B
Minority Interest, Total (Incl. Fin. Div)	28.9M	22.5M	27.5M	31.9M	33.7M
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-115M	-179M	-119M	-105M	-92M
Inventories - Raw Materials, Total	596M	849M	705M	607M	620M
Inventories - Finished Goods, Total	1.01B	1.12B	911M	962M	962M
Land - (BS)	159M	161M	156M	144M	149M
Buildings, Total	1.13B	1.13B	1.17B	1.15B	1.24B
Machinery, Total	4.68B	4.6B	4.87B	5.17B	5.69B
Full Time Employees	47K	47K	48K	48K	48K
Accumulated Allowance for Doubtful Accounts (Supple)	71.5M	131M	149M	122M	117M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.13B	1.09B	1.37B	2.11B	2.08B
Depreciation & Amortization - CF	604M	618M	617M	635M	673M
Amortization of Goodwill and Intangible Assets - (CF)	239M	320M	307M	300M	304M
Depreciation & Amortization, Total	843M	939M	924M	935M	976M
(Gain) Loss From Sale Of Asset	-	-	-	-382M	1.1M
Asset Writedown & Restructuring Costs	-41.7M	66.2M	-32.6M	23.7M	18.8M
Stock-Based Compensation (CF)	89.5M	87.8M	95.1M	135M	137M
Tax Benefit from Stock Options	-	-	-	-	-
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	40.5M	-119M	-109M	-187M	-49.7M
Change In Accounts Receivable	-178M	-320M	-84.3M	-147M	-186M
Change In Inventories	-73M	-403M	320M	-116M	36.4M
Change In Accounts Payable	200M	395M	-232M	300M	67.7M
Change in Other Net Operating Assets	51.4M	51.1M	159M	138M	-124M
Cash from Operations	2.06B	1.79B	2.41B	2.81B	2.95B
Capital Expenditure	-643M	-713M	-775M	-994M	-1.05B
Sale of Property, Plant, and Equipment	12.2M	2.2M	9.9M	11.3M	52.3M
Cash Acquisitions	-3.92B	-7.2M	-180M	-313M	-1.62B
Divestitures	-	-	-	890M	-14.9M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Other Investing Activities, Total	-25.2M	1M	-45.2M	-27.4M	-75M
Cash from Investing	-4.58B	-717M	-990M	-434M	-2.71B
Short Term Debt Issued, Total	394M	-	-	1.9M	98.2M
Long-Term Debt Issued, Total	2.78B	494M	-	-	1.05B
Total Debt Issued	3.17B	494M	-	1.9M	1.14B
Short Term Debt Repaid, Total	-	-404M	-1.9M	-	-
Long-Term Debt Repaid, Total	-1.05B	-	-500M	-630M	-674M
Total Debt Repaid	-1.05B	-404M	-502M	-630M	-674M
Issuance of Common Stock	144M	29.1M	96.8M	259M	228M
Repurchase of Common Stock	-107M	-518M	-13.7M	-986M	-784M
Common Dividends Paid	-566M	-603M	-617M	-664M	-754M
Common & Preferred Stock Dividends Paid	-566M	-603M	-617M	-664M	-754M
Other Financing Activities, Total	11.4M	165M	-18.6M	-4.2M	-13.7M
Cash from Financing	1.6B	-837M	-1.05B	-2.02B	-853M
Foreign Exchange Rate Adjustments	14.3M	4.4M	-45.7M	-18.7M	-2.7M
Net Change in Cash	-900M	239M	321M	337M	-611M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	276M	309M	469M	647M	548M
Levered Free Cash Flow	1.1B	1.31B	1.55B	1.93B	1.64B
Unlevered Free Cash Flow	1.22B	1.47B	1.77B	2.15B	1.83B
Change In Net Working Capital	232M	-1.5M	-163M	-401M	75.7M
Net Debt Issued / Repaid	2.12B	89.7M	-502M	-628M	470M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.94	5.42	6.3	7.55	7.84
Return on Total Capital	7.85	7.07	8.25	9.85	10.28
Return On Equity %	17.01	15.28	18.17	25.29	22.52
Return on Common Equity	16.88	15.1	17.96	25.14	22.4
Margin Analysis
Gross Profit Margin %	40.93	38.25	40.39	43.5	44.51
SG&A Margin	26.26	25.22	26.14	26.53	26.16
EBITDA Margin %	21.29	19.65	20.28	22.9	24.43
EBITA Margin %	16.54	15.29	16.26	18.87	20.24
EBIT Margin %	14.67	13.03	14.25	16.96	18.35
Income From Continuing Operations Margin %	8.98	7.82	9.09	13.54	13.02
Net Income Margin %	8.87	7.69	8.96	13.42	12.91
Net Avail. For Common Margin %	8.87	7.69	8.96	13.42	12.91
Normalized Net Income Margin	8.14	6.95	7.57	9.36	10.42
Levered Free Cash Flow Margin	8.65	9.26	10.14	12.28	10.21
Unlevered Free Cash Flow Margin	9.62	10.37	11.57	13.63	11.4
Asset Turnover
Asset Turnover	0.65	0.66	0.71	0.71	0.68
Fixed Assets Turnover	3.52	3.82	3.94	3.7	3.38
Receivables Turnover (Average Receivables)	5.36	5.48	5.54	5.52	5.16
Inventory Turnover (Average Inventory)	5.42	5.33	5.55	6.01	6.04
Short Term Liquidity
Current Ratio	1.32	1.3	1.3	1.26	1.08
Quick Ratio	0.84	0.83	0.91	0.89	0.77
Operating Cash Flow to Current Liabilities	0.58	0.42	0.55	0.59	0.53
Days Sales Outstanding (Average Receivables)	68.11	66.59	65.9	66.26	70.72
Days Outstanding Inventory (Average Inventory)	67.38	68.42	65.75	60.94	60.44
Average Days Payable Outstanding	60.09	62.68	68.04	69.72	79.15
Cash Conversion Cycle (Average Days)	75.4	72.33	63.61	57.48	52.02
Long Term Solvency
Total Debt/Equity	126.23	124.36	108.19	94.24	91.77
Total Debt / Total Capital	55.8	55.43	51.97	48.52	47.85
LT Debt/Equity	118.98	115.91	98.82	85.61	81.21
Long-Term Debt / Total Capital	52.59	51.66	47.47	44.08	42.35
Total Liabilities / Total Assets	65.8	66.18	63.05	60.74	60.3
EBIT / Interest Expense	9.46	7.33	6.26	7.85	9.64
EBITDA / Interest Expense	14.63	11.84	9.52	11.24	13.58
(EBITDA - Capex) / Interest Expense	11.38	9.01	7.3	8.31	10.16
Total Debt / EBITDA	3.17	3.02	2.63	2.17	2.16
Net Debt / EBITDA	3.04	2.82	2.35	1.84	2.01
Total Debt / (EBITDA - Capex)	4.07	3.97	3.43	2.93	2.89
Net Debt / (EBITDA - Capex)	3.91	3.71	3.07	2.48	2.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	8	11.42	7.98	2.75	2.16
Gross Profit, 1 Yr. Growth %	5.65	4.14	14.02	10.65	4.54
EBITDA, 1 Yr. Growth %	8.57	2.83	11.49	15.94	8.94
EBITA, 1 Yr. Growth %	10.72	2.98	14.86	19.16	9.59
EBIT, 1 Yr. Growth %	10.91	-1.01	18.15	22.14	10.54
Earnings From Cont. Operations, 1 Yr. Growth %	16.17	-3.07	25.62	53.04	-1.81
Net Income, 1 Yr. Growth %	-193.76	-3.38	25.7	53.93	-1.74
Normalized Net Income, 1 Yr. Growth %	14.73	-4.92	17.72	26.94	13.83
Diluted EPS Before Extra, 1 Yr. Growth %	17.42	-2.56	25.72	53.86	-1.22
Accounts Receivable, 1 Yr. Growth %	9	8.86	5.04	1.09	17.51
Inventory, 1 Yr. Growth %	16.08	20.18	-16.49	-2.16	1.74
Net Property, Plant and Equip., 1 Yr. Growth %	3.85	1.53	7.66	11.11	12.67
Total Assets, 1 Yr. Growth %	16.99	1.22	1.78	2.48	10.31
Tangible Book Value, 1 Yr. Growth %	79.73	-11.98	-19.3	-31.64	27.9
Common Equity, 1 Yr. Growth %	17.15	0.16	11.17	8.86	11.57
Cash From Operations, 1 Yr. Growth %	10.84	-13.26	34.86	16.67	4.93
Capital Expenditures, 1 Yr. Growth %	31.49	10.86	8.7	28.36	5.41
Levered Free Cash Flow, 1 Yr. Growth %	-39.95	19.24	18.37	24.27	-15.04
Unlevered Free Cash Flow, 1 Yr. Growth %	-37.89	20.09	20.52	20.99	-14.54
Dividend Per Share, 1 Yr. Growth %	3.17	5.64	4.85	9.26	13.56
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.68	9.7	9.69	5.33	2.45
Gross Profit, 2 Yr. CAGR %	-3.14	4.89	8.97	12.33	7.56
EBITDA, 2 Yr. CAGR %	-2.7	5.66	7.09	13.75	12.39
EBITA, 2 Yr. CAGR %	-4.18	6.78	8.77	17.05	14.27
EBIT, 2 Yr. CAGR %	-5.42	4.78	8.17	20.2	16.2
Earnings From Cont. Operations, 2 Yr. CAGR %	-10.96	6.11	10.35	38.66	22.59
Net Income, 2 Yr. CAGR %	-14.86	-4.82	10.21	39.1	22.98
Normalized Net Income, 2 Yr. CAGR %	-5.88	4.44	5.8	22.24	20.2
Diluted EPS Before Extra, 2 Yr. CAGR %	-10.4	6.96	10.68	39.08	23.28
Accounts Receivable, 2 Yr. CAGR %	2	8.93	6.94	3.05	8.99
Inventory, 2 Yr. CAGR %	17.44	18.11	0.18	-9.61	-0.23
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.13	2.68	4.55	9.37	11.89
Total Assets, 2 Yr. CAGR %	0.8	8.82	1.5	2.13	6.32
Tangible Book Value, 2 Yr. CAGR %	418.03	25.78	-15.72	-25.73	-6.5
Common Equity, 2 Yr. CAGR %	-8.8	8.33	5.53	10.01	10.21
Cash From Operations, 2 Yr. CAGR %	-7.71	-1.95	8.15	25.44	10.64
Capital Expenditures, 2 Yr. CAGR %	-6.23	20.73	9.77	18.12	16.32
Levered Free Cash Flow, 2 Yr. CAGR %	-9.29	-15.38	18.83	21.35	2.76
Unlevered Free Cash Flow, 2 Yr. CAGR %	-8.8	-13.64	20.33	20.81	1.68
Dividend Per Share, 2 Yr. CAGR %	2.67	4.4	5.25	7.03	11.39
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.37	4.14	9.12	7.33	4.26
Gross Profit, 3 Yr. CAGR %	-0.88	-0.77	7.85	9.53	9.67
EBITDA, 3 Yr. CAGR %	0.7	-0.89	7.56	9.99	12.12
EBITA, 3 Yr. CAGR %	-0.19	-1.85	9.39	12.17	14.51
EBIT, 3 Yr. CAGR %	-0.99	-3.97	9.04	12.68	16.89
Earnings From Cont. Operations, 3 Yr. CAGR %	-3.32	-8.4	12.25	23.06	23.59
Net Income, 3 Yr. CAGR %	-7.53	-11.2	4.43	23.19	23.88
Normalized Net Income, 3 Yr. CAGR %	-0.43	-5.56	8.69	12.42	19.37
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.89	-7.86	12.88	23.53	24.09
Accounts Receivable, 3 Yr. CAGR %	-2.36	4.24	7.62	4.95	7.66
Inventory, 3 Yr. CAGR %	-1.19	18.35	5.22	-0.6	-5.97
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.33	0.42	4.31	6.69	10.46
Total Assets, 3 Yr. CAGR %	1.85	0.94	6.42	1.82	4.79
Tangible Book Value, 3 Yr. CAGR %	20.8	186.92	8.48	-21.4	-10.98
Common Equity, 3 Yr. CAGR %	-3.36	-5.9	9.27	6.63	10.53
Cash From Operations, 3 Yr. CAGR %	-3.26	-9.6	9.04	10.92	18.19
Capital Expenditures, 3 Yr. CAGR %	-6.18	-0.85	16.58	15.65	13.72
Levered Free Cash Flow, 3 Yr. CAGR %	5.18	-0.63	-5.38	20.66	7.76
Unlevered Free Cash Flow, 3 Yr. CAGR %	3.85	-0.04	-3.51	20.58	7.64
Dividend Per Share, 3 Yr. CAGR %	4.89	3.65	4.55	6.57	9.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-0.64	0.5	4.62	4.62	6.4
Gross Profit, 5 Yr. CAGR %	-1.72	-1.38	2.95	4.27	7.73
EBITDA, 5 Yr. CAGR %	-1.14	-1.13	3.2	4.72	9.49
EBITA, 5 Yr. CAGR %	-1.82	-1.72	3.28	5.3	11.34
EBIT, 5 Yr. CAGR %	-1.55	-2.12	2.56	5.04	11.88
Earnings From Cont. Operations, 5 Yr. CAGR %	-1.7	-6.09	1.93	8.12	16.28
Net Income, 5 Yr. CAGR %	-1.67	-6.21	-0.81	6.27	11.49
Normalized Net Income, 5 Yr. CAGR %	-0.81	-2.64	2.02	4.71	13.16
Diluted EPS Before Extra, 5 Yr. CAGR %	-1.14	-5.74	2.32	8.64	16.93
Accounts Receivable, 5 Yr. CAGR %	1.15	0.97	1.26	3.76	8.17
Inventory, 5 Yr. CAGR %	2.49	4.39	-0.64	6.25	3.01
Net Property, Plant and Equip., 5 Yr. CAGR %	1.84	0.19	0.98	3.91	7.28
Total Assets, 5 Yr. CAGR %	2.96	1.46	1.71	1.41	6.38
Tangible Book Value, 5 Yr. CAGR %	8.94	4.36	4.6	67.11	2.22
Common Equity, 5 Yr. CAGR %	0.92	-0.93	0.1	0.17	9.64
Cash From Operations, 5 Yr. CAGR %	1.23	-3.08	1.15	3.06	9.68
Capital Expenditures, 5 Yr. CAGR %	-3.21	-3.88	-0.1	6.34	16.48
Levered Free Cash Flow, 5 Yr. CAGR %	-7.02	1.07	10.42	7.63	-2.18
Unlevered Free Cash Flow, 5 Yr. CAGR %	-7.03	0.95	10.13	7.82	-1.44
Dividend Per Share, 5 Yr. CAGR %	6.55	6.27	5.03	4.99	7.23